A pharmacometrics model to define docetaxel target in early breast cancer
Aims: We aimed to study the relation between pharmacokinetics (PK) and pharmacodynamics (PD) of docetaxel in early breast cancer and recommend a target exposure. Methods: A PK/PD study was performed in 27 early breast cancer patients treated with doxorubicin and cyclophosphamide for 4 cycles foll...
| Autors principals: | , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Idioma: | eng |
| Publicat: |
Wiley
2023
|
| Matèries: | |
| Accés en línia: | https://hdl.handle.net/10171/66083 |